Optimizing immunosuppression: who can do more with less?

被引:0
作者
Flechner, Stuart M. [1 ]
机构
[1] Cleveland Clin, Lerner Coll Med, Glickman Urol & Kidney Inst, Cleveland, OH 44195 USA
关键词
HLA ANTIBODIES; KIDNEY; SURVIVAL;
D O I
10.1111/tri.12676
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:20 / 22
页数:3
相关论文
共 10 条
[1]   Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation [J].
Hourmant, M ;
Cesbron-Gautier, A ;
Terasaki, PI ;
Mizutani, K ;
Moreau, A ;
Meurette, A ;
Dantal, J ;
Giral, M ;
Blancho, G ;
Cantarovich, D ;
Karam, G ;
Follea, G ;
Soulillou, JP ;
Bignon, JD .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (09) :2804-2812
[2]   Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal [J].
Lamb, K. E. ;
Lodhi, S. ;
Meier-Kriesche, H. -U .
AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (03) :450-462
[3]   Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival [J].
Loupy, Alexandre ;
Lefaucheur, Carmen ;
Vernerey, Dewi ;
Prugger, Christof ;
van Huyen, Jean-Paul Duong ;
Mooney, Nuala ;
Suberbielle, Caroline ;
Fremeaux-Bacchi, Veronique ;
Mejean, Arnaud ;
Desgrandchamps, Francois ;
Anglicheau, Dany ;
Nochy, Dominique ;
Charron, Dominique ;
Empana, Jean-Philippe ;
Delahousse, Michel ;
Legendre, Christophe ;
Glotz, Denis ;
Hill, Gary S. ;
Zeevi, Adriana ;
Jouven, Xavier .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13) :1215-1226
[4]   OPTN/SRTR 2013 Annual Data Report: kidney [J].
Matas, A. J. ;
Smith, J. M. ;
Skeans, M. A. ;
Thompson, B. ;
Gustafson, S. K. ;
Stewart, D. E. ;
Cherikh, W. S. ;
Wainright, J. L. ;
Boyle, G. ;
Snyder, J. J. ;
Israni, A. K. ;
Kasiske, B. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 :1-34
[5]  
Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009
[6]   Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant [J].
Opelz, Gerhard ;
Doehler, Bernd .
TRANSPLANTATION, 2008, 86 (03) :371-376
[7]   Medical progress - Strategies to improve long-term outcomes after renal transplantation [J].
Pascual, M ;
Theruvath, T ;
Kawai, T ;
Tolkoff-Rubin, N ;
Cosimi, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (08) :580-590
[8]   Understanding the Causes of Kidney Transplant Failure: The Dominant Role of Antibody-Mediated Rejection and Nonadherence [J].
Sellares, J. ;
de Freitas, D. G. ;
Mengel, M. ;
Reeve, J. ;
Einecke, G. ;
Sis, B. ;
Hidalgo, L. G. ;
Famulski, K. ;
Matas, A. ;
Halloran, P. F. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (02) :388-399
[9]  
Thierry A, 2015, TRANSPL INT, V29, P22
[10]   Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant [J].
Wiebe, C. ;
Gibson, I. W. ;
Blydt-Hansen, T. D. ;
Karpinski, M. ;
Ho, J. ;
Storsley, L. J. ;
Goldberg, A. ;
Birk, P. E. ;
Rush, D. N. ;
Nickerson, P. W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (05) :1157-1167